What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Research
NCT06796062 - Psilocybin for Opioid Use Disorder (OUD)
Clinical Trial in Albuquerque, New Mexico
This is a double-blind, adaptive, 2-stage, multi-site, phase 2 randomized controlled clinical trial designed to evaluate effects of moderate and high dose psilocybin, relative to low-dose psilocybin control, in OUD patients who continue to use illicit opioids in spite of adherence to standard-of-care treatment with methadone. Up to 480 participations will be consented to yield 240 randomized participants. This stu... Source record lists lead sponsor NYU Langone Health and overall status Recruiting.
Clinical TrialResearch
Directory Facts
- Status
- Verified from official/source records
- Price
- Free study screening / research participation
- Hours
- Verify with provider
- License / Record
- NCT06796062
- Last Verified
- 2026-06-12
Location
Duke City Recovery Toolbox, Albuquerque, New Mexico
Source Notes
Discovery row generated from the official ClinicalTrials.gov API record for NCT06796062; status Recruiting; sponsor NYU Langone Health.
Source: https://clinicaltrials.gov/study/NCT06796062
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.